Killing Cancer Cells with the Help of Infrared Light - Photoimmunotherapy
Near-infrared photoimmunotherapy uses an antibody–photoabsorber conjugate that binds to cancer cells. When near-infrared light is applied, the cells swell and then burst, causing the cancer cell to die. Photoimmunotherapy is in clinical trials in patients with inoperable tumors. For more information, please visit http://www.cancer.gov/photoimmunotherapy
▶︎
Immunotherapy: How the Immune System Fights Cancer
▶︎
Your National Cancer Institute. Driving Cancer Breakthroughs. (Open Captions)
▶︎
How Monoclonal Antibodies Treat Cancer
▶︎
Risk Factors for Cancer | Did You Know?
▶︎
Center for Cancer Research Focus RT Clinical Trial for Prostate Cancer: Frequently Asked Questions
▶︎
ProAE R Package: Advanced Tools for Patient-Reported Adverse Event Analysis in Clinical Trials
▶︎
Neuro-Oncology Branch Shapes the Next Generation of Researchers and Clinicians
▶︎
How Patient-Reported Bother by Side Effects Predicts Cancer Treatment Discontinuation
▶︎
Childhood Cancer Data Initiative Hub Explore Dashboard Tutorial
▶︎
Understanding the Toxicity Index: A Superior Measure for Adverse Event Analysis
▶︎
International Cancer Proteogenome Consortium
![Your National Cancer Institute. Driving Cancer Breakthroughs. [Extended Version]](https://i.ytimg.com/vi/qL2Ovw21oDA/hqdefault.jpg?sqp=-oaymwEjCNACELwBSFryq4qpAxUIARUAAAAAGAElAADIQj0AgKJDeAE=&rs=AOn4CLDzNVyiXytT8reoy7Pw-wzm0JbSow)
▶︎
Your National Cancer Institute. Driving Cancer Breakthroughs. [Extended Version]
▶︎
Introducing the Breast Cancer Symptom Explorer: Visualizing Adverse Events and Quality of Life
▶︎
Improving Cancer Care for Older Adults: The Role of Geriatric Assessments
▶︎
Lacey Koelling — CCR Patients Perspective
▶︎
Office of Cancer Survivorship Vision, Mission, and Future
▶︎